首页良性前列腺增生治疗及预后证据详情

Medium-term Outcomes of Urolift (Minimum 12 Months Follow-up): Evidence From a Systematic Review

原文:2016年 发布于 Urology 浏览量:1419次 原文链接

作者: Jones P. Rajkumar G. N. Rai B. P. Aboumarzouk O. M. Cleaveland P. Srirangam S. J. Somani B. K.

作者单位: Department of Urology, Royal Blackburn Hospital, United Kingdom. Electronic address: patrick.jones1@nhs.net. Basingstoke and North Hampshire Hospital, United Kingdom. The Lister Hospital, Stevenage, United Kingdom. Department of Urology, Wales Deanery, Cardiff, Wales, United Kingdom. Department of Urology, Royal Blackburn Hospital, United Kingdom. Department of Urology, University Hospital Southampton, Southampton, United Kingdom.

归属分类: 良性前列腺增生治疗及预后证据

DOI: 10.1016/j.urology.2016.05.003

关键词: Follow-Up Studies Humans Length of Stay Male Operative Time Postoperative Complications/etiology Prostatic Hyperplasia/complications Prostatism/etiology *Prostheses and Implants Quality of Life Severity of Illness Index Time Factors

文献简介

The urolift device has emerged as a novel intervention for men with lower urinary tract symptoms secondary to benign prostatic hyperplasia, and in recent years there has been an increasing amount of primary research published on it. However, critical medium-term appraisal remains lacking. Our objective was to perform a systematic review and therefore identify, appraise, and synthesize the existing evidence for the minimally invasive technique.

热门文献